Neola Medical

Neola Medical R&D per Employee

R&D Spending per Employee of Neola Medical (NEOLA.ST) as of Oct 16, 2026.

R&D per Employee

-SEK

Last updated:

R&D Spending per Employee of Neola Medical is 2026 - SEK. R&D Spending per Employee of Neola Medical was 2025 - SEK. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Neola Medical Stock analysis

What does Neola Medical do? Neola Medical AB is a healthcare company headquartered in Lund, Sweden. The company focuses on the research, development, and commercialization of medical devices. Neola Medical's technology centers on continuous lung monitoring for premature babies using patented GASMAS (Gas in Scattering Media Absorption Spectroscopy) technology. The company went public on October 2, 2020. Its primary product, NEOLA, provides continuous lung monitoring and real-time alerts for life-threatening complications in neonatal intensive care. Neola Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neola Medical stock

On Eulerpool you can find the complete historical development of R&D Spending per Employee Neola Medical since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Neola Medical historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Neola Medical

All Key Metrics — Neola Medical